Skip to Content

Ongoing Anticoagulant Use Does Not Avert Severe COVID-19

FRIDAY, Dec. 4, 2020 -- Direct oral anticoagulant (DOAC) use is not associated with a reduction in the risk for severe COVID-19, according to a study published online Dec. 1 in the Journal of Internal Medicine.

Benjamin Flam, M.D., from the Karolinska University Hospital in Stockholm, and colleagues examined whether ongoing DOAC use was associated with a reduced risk for hospital admission for laboratory-confirmed COVID-19 in a nationwide register-based cohort study in Sweden in February through May 2020.

The researchers observed no association for DOAC use with a reduced risk for hospital admission for COVID-19 compared with nonuse in a comparator group of patients with atrial fibrillation (adjusted hazard ratio, 1.00; 95 percent confidence interval, 0.75 to 1.33) and in a comparator group of patients with cardiovascular disease (adjusted hazard ratio, 0.94; 95 percent confidence interval, 0.80 to 1.10). In addition, no association was seen for DOAC use with intensive care unit admission or death due to COVID-19 (adjusted hazard ratios, 0.76 [95 percent confidence interval, 0.51 to 1.12] and 0.90 [95 percent confidence interval, 0.71 to 1.15], respectively).

"Our findings suggest that early DOAC treatment doesn't protect against severe COVID-19, but these should be treated with caution since there might remain differences between the groups that are difficult to measure," Flam said in a statement. "Also, our study says nothing about whether other types of anticoagulants could be effective, but a good many clinical studies are being done around the world."

The study was funded by Janssen Corporation.

Abstract/Full Text (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.

Posted: December 2020

Read this next

Vitamin D Deficiency Associated With Increased COVID-19 Risk

MONDAY, Jan. 25, 2021 -- Patients with vitamin D deficiency are significantly more likely to be positive for COVID-19, according to a study published in the April issue of...

Full-Dose Heparin May Aid Moderately Ill COVID-19 Patients

MONDAY, Jan. 25, 2021 -- Evidence suggests that full-dose anticoagulation treatment reduces the need for vital organ support such as ventilation and may reduce mortality in...

Children Less Susceptible to SARS-CoV-2 but More Infectious

MONDAY, Jan. 25, 2021 -- Children and adolescents are less susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but are more infectious than...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.